Pfizer has committed $650 million upfront in a collaboration with Innovent Biologics that could ultimately reach $10.5 ...
The FDA has expanded the label for guselkumab (Tremfya) to include evidence that it can inhibit progression of structural ...
Exposure to systemic glucocorticoid immunosuppression (gsISP) close to immune checkpoint inhibitor (ICI) initiation was ...
Incorporating procalcitonin-guided decision making in the management of neonatal late-onset sepsis significantly reduced the ...
In this randomized controlled trial, tirzepatide produced substantially greater reductions in HbA1c, body weight, waist ...
Adding a thrombolytic agent delivered through the arterial catheter immediately following mechanical clot extraction ...
In this randomized controlled trial, household contacts of patients with Covid-19 who received ensitrelvir shortly after ...
In this randomized controlled trial, acute stroke patients with medium-vessel occlusion and moderate-to-severe neurological ...
Caloric restriction and intermittent fasting show mixed human longevity data Caloric restriction remains one of the most robust interventions for ...
1. Initiation of centrally acting analgesics in patients with osteoarthritis (OA) was associated with a higher long-term risk of total ...
Visual Abstracts. 2 Minute Medicine is the largest publisher of visual abstracts – more than any medical journal. Classics in Medicine™ Online Access – Unlimited reading of the Classics in Medicine™ – ...
1. In this randomized controlled trial, bottom‑vented bottles did not reduce mild gastrointestinal discomfort overall in infants aged 0–90 days. Evidence Rating Level: 1 (Excellent) Bottle feeding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results